Novartis Corporation and Speedel Pharmaceuticals, Inc. at Loggerheads Over Tekturna Royalties

15 November 2007 -- Speedel has had a major falling-out with its fellow Swiss, but much bigger, partner Novartis over monies that the former believes it is owed relating to the new antihypertensive Tekturna/Rasilez.

MORE ON THIS TOPIC